AlzChem Group AG/€ACT
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About AlzChem Group AG
AlzChem Group AG operates within the chemical industry, focusing on the production and distribution of specialty chemicals. The company offers a wide range of products, including nitrile and guanidine derivatives, which are used in various applications such as agriculture, pharmaceuticals, and renewable energy. Headquartered in Trostberg, Germany, AlzChem has a strong foundation in the region but exports its products globally. The company's strategic positioning leverages its specialized product offerings and research capabilities, enabling it to serve niche markets with high-value solutions. AlzChem's history includes a rich legacy of chemical expertise and innovation that began at its founding.
Ticker
€ACT
Sector
Primary listing
XETRA
Employees
1,647
Headquarters
Website
AlzChem Group AG Metrics
BasicAdvanced
€1.4B
24.82
€5.71
0.80
€1.80
1.27%
Price and volume
Market cap
€1.4B
Beta
0.8
52-week high
€169.00
52-week low
€39.84
Average daily volume
6.8K
Dividend rate
€1.80
Financial strength
Current ratio
2.841
Quick ratio
1.729
Long term debt to equity
18.058
Total debt to equity
21.758
Dividend payout ratio (TTM)
31.40%
Interest coverage (TTM)
41.80%
Profitability
EBITDA (TTM)
105.739
Gross margin (TTM)
62.15%
Net profit margin (TTM)
10.29%
Operating margin (TTM)
14.53%
Effective tax rate (TTM)
27.82%
Revenue per employee (TTM)
€340,000
Management effectiveness
Return on assets (TTM)
10.12%
Return on equity (TTM)
28.91%
Valuation
Price to earnings (TTM)
24.815
Price to revenue (TTM)
2.554
Price to book
6.59
Price to tangible book (TTM)
6.7
Price to free cash flow (TTM)
34.752
Free cash flow yield (TTM)
2.88%
Free cash flow per share (TTM)
4.08
Dividend yield (TTM)
1.27%
Forward dividend yield
1.27%
Growth
Revenue change (TTM)
2.07%
Earnings per share change (TTM)
25.37%
3-year revenue growth (CAGR)
4.93%
3-year earnings per share growth (CAGR)
27.67%
3-year dividend per share growth (CAGR)
21.64%
Bulls say / Bears say
In Q2 2025, AlzChem’s revenue climbed nearly 5% year-on-year to €142.9 million and EBITDA rose nearly 8% to €29.1 million, reflecting robust demand for higher-margin specialty chemicals (MarketScreener).
In FY 2024, AlzChem achieved a record EBITDA of €105.3 million, a 29.4% increase year-on-year, with the specialty chemicals segment driving margin expansion to 19.0% (AlzChem Corporate News).
The expansion of nitroguanidine production capacity in Germany remains on schedule and within budget, and site selection for a U.S. facility is underway, supporting future volume growth (MarketScreener).
In the first half of 2025, sales in the Basics & Intermediates segment fell 14% to €78.2 million and segment EBITDA declined to €1.3 million due to weak European steel demand and intensified price competition from Chinese suppliers (WebDisclosure).
After reaching an all-time high near €167 in mid-2025, AlzChem’s stock slid about 17% as profit-taking set in, underscoring volatility despite a more than doubling of the share price year-to-date (MarketScreener).
Operating cash flow in H1 2025 was buoyed by €51.0 million of customer grants for capacity expansion, and free cash flow declined from €51.4 million to €30.7 million, highlighting dependence on non-operational cash receipts (Finanzen.ch).
Data summarised monthly by Lightyear AI. Last updated on 5 Sept 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for AlzChem Group AG stock?
AlzChem Group AG (ACT) has a market cap of €1.4B as of September 14, 2025.
What is the P/E ratio for AlzChem Group AG stock?
The price to earnings (P/E) ratio for AlzChem Group AG (ACT) stock is 24.82 as of September 14, 2025.
Does AlzChem Group AG stock pay dividends?
Yes, the AlzChem Group AG (ACT) stock pays dividends to shareholders. As of September 14, 2025, the dividend rate is €1.8 and the yield is 1.27%. AlzChem Group AG has a payout ratio of 31.4% on a trailing twelve-month basis.
When is the next AlzChem Group AG dividend payment date?
The next AlzChem Group AG (ACT) dividend payment date is unconfirmed.
What is the beta indicator for AlzChem Group AG?
AlzChem Group AG (ACT) has a beta rating of 0.8. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.